Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer

por Palmieri, Carlo, Macpherson, Iain RJ, Yan, Kelvin, Ades, Felipe, Riddle, Pippa, Ahmed, Riz, Owadally, Waheeda, Stanley, Barbara, Shah, Deep, Gojis, Ondrej, Januszewski, Adam, Lewanski, Conrad, Asher, Rebecca, Lythgoe, Daniel, de Azambuja, Evandro, Beresford, Mark, Howell, Sacha J.
Publicado 2015

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

por Ross-Innes, Caryn S., Stark, Rory, Teschendorff, Andrew E., Holmes, Kelly A., Ali, H. Raza, Dunning, Mark J., Brown, Gordon D., Gojis, Ondrej, Ellis, Ian O., Green, Andrew R., Ali, Simak, Chin, Suet-Feung, Palmieri, Carlo, Caldas, Carlos, Carroll, Jason S.
Publicado 2012